Cellid Balance Sheet Health
Financial Health criteria checks 5/6
Cellid has a total shareholder equity of ₩40.5B and total debt of ₩12.0B, which brings its debt-to-equity ratio to 29.6%. Its total assets and total liabilities are ₩63.9B and ₩23.4B respectively.
Key information
29.6%
Debt to equity ratio
₩11.98b
Debt
Interest coverage ratio | n/a |
Cash | ₩15.41b |
Equity | ₩40.50b |
Total liabilities | ₩23.43b |
Total assets | ₩63.92b |
Financial Position Analysis
Short Term Liabilities: A299660's short term assets (₩16.9B) exceed its short term liabilities (₩10.3B).
Long Term Liabilities: A299660's short term assets (₩16.9B) exceed its long term liabilities (₩13.1B).
Debt to Equity History and Analysis
Debt Level: A299660 has more cash than its total debt.
Reducing Debt: A299660's debt to equity ratio has increased from 0% to 29.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A299660 has sufficient cash runway for 10 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: A299660 is forecast to have sufficient cash runway for 11 months based on free cash flow estimates, but has since raised additional capital.